DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Femring (Estradiol Acetate Vaginal) - Published Studies

 
 



Femring Related Published Studies

Well-designed clinical trials related to Femring (Estradiol Vaginal)

Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial. [2014]

[Impacts on the duration of vaginal bleeding and the levels of serum estradiol (E2) and progesterone (P) for patients of midtrimester induction of labor treated with moxibustion at Guanyuan (CV 4) and Shenque (CV 8)]. [2011.09]

Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women. [2011.08]

[Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study]. [2011.05]

The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. [2011.03]

[Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study]. [Article in Chinese] [2011]

Endometrial safety of ultra-low-dose estradiol vaginal tablets. [2010.10]

Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns. [2010.10]

Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study. [2010.09]

Minimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tablets. [2010.06]

The use of oestradiol therapy in postmenopausal women after TVT-O anti-incontinence surgery. [2010.05]

Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes. [2010.05]

The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. [2010.02.05]

A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial. [2010.01]

Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. [2009.12]

Effects of variations in serum estradiol concentrations on secretory endometrial development and function in experimentally induced cycles in normal women. [2009.12]

Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial. [2009.10]

Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause. [2009.08]

Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial. [2009.08]

Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen. [2009.07]

[Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis] [2009.07]

Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial. [2009.05.25]

Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium-A randomized controlled trial. [2009.01.20]

Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. [2009.01]

Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. [2008.11]

The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women. [2008.03]

The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. [2008.03]

Efficacy of Low-Dose Estradiol Vaginal Tablets in the Treatment of Atrophic Vaginitis: A Randomized Controlled Trial. [2008.01]

The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. [2007.08.01]

One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. [2007.06.20]

Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study. [2007.06]

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. [2007.05]

Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. [2007.04]

Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial. [2007.03]

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. [2007.01.11]

Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial. [2006.12]

Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index. [2006.09]

Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables. [2006.07]

Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials. [2006.06]

Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms. [2006.05]

Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years. [2006.01]

Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive. [2006.01]

Feasibility study of Nestorone(R)-ethinylestradiol vaginal contraceptive ring for emergency contraception. [2006.01]

Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms. [2005.11]

Bleeding patterns during continuous estradiol with different sequential progestogens therapy. [2005.09]

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. [2005.09]

Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen. [2005.07]

Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen. [2005.07]

Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms. [2005.05]

Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate. [2005.05]

Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. [2005.04]

Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. [2005.03]

Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis. [2005.02.14]

Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial. [2005.02]

Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women. [2005.01]

A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol. [2004.10.15]

Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. [2004]

Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles. [2004]

Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms. [2003.10]

The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women. [2003.08]

Placement of the vaginal 17beta-estradiol tablets in the inner or outer one third of the vagina affects the preferential delivery of 17beta-estradiol toward the uterus or periurethral areas, thereby modifying efficacy and endometrial safety. [2003.07]

A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women. [2003.06]

Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms. [2003.06]

A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate. [2003.02]

Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. [2003.01]

Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women. [2003.01]

[Prevention of bone loss by estradiol valerate combined with medroxyprogesterone acetate among postmenopausal women with osteopenia] [2002.12.10]

Endometrial thickness and uterine diameter not affected by ultralow doses of 17beta-estradiol in elderly women. [2002.05]

Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials. [2002.05]

Estradiol absorption from vaginal tablets in postmenopausal women. [2002.04]

Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study. [2002.04]

Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. [2002.03]

The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. [2002.03]

Outpatient cervical ripening with prostaglandin E2 and estradiol. [2002.02]

Growth of the uterus and mammary glands and vaginal cytologic features in extremely premature infants with postnatal replacement of estradiol and progesterone. [2002.02]

Sequential hormonal supplementation with vaginal estradiol and progesterone gel corrects the effect of clomiphene on the endometrium in oligo-ovulatory women. [2002.02]

The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study. [2001.10]

Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women--a double-blind placebo-controlled study. [2001.07]

Serum lipid profile improved by ultra-low doses of 17 beta-estradiol in elderly women. [2001.06]

Is there evidence for preferential delivery of ovarian estradiol to the endometrium? [2001.06]

Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding. [2000.12]

Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. [2000.09]

Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol. [2000.09]

Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators. [2000.09]

Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. [2000.08]

Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women. [2000.06]

17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. [2000.05]

Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women. [2000.04.28]

Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. [2000.04]

Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints. [2000.02.15]

A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women. [2000.02.15]

Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest and Climara. [2000.01.15]

Estradiol-delivering vaginal rings for hormone replacement therapy. [1999.12]

Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies. [1999.11]

Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone. [1999.06]

Serum and tissue hormone levels of vaginally and orally administered estradiol. [1999.06]

A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol. [1999.05]

A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. [1999.05]

Relationship of estradiol levels to breakthrough bleeding during continuous combined hormone replacement therapy. [1999.04]

Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Alora Study Group. [1999.03]

Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. [1999.01]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017